SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma recalls 13,834 bottles of diabetes drug ‘Riomet’ in US market

26 Apr 2021 Evaluate

Sun Pharma is recalling 13,834 bottles of diabetes drug Riomet (metformin hydrochloride oral solution) in the US due to ‘microbial contamination of non-sterile product’. The affected lot has been distributed in the US by New Jersey-based Sun Pharmaceutical Industries Inc. The company initiated Class II nationwide recall on March 31 this year.

Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1669.95 1.95 (0.12%)
21-Apr-2026 09:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.95
Dr. Reddys Lab 1242.75
Cipla 1230.00
Zydus Lifesciences 935.00
Lupin 2337.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×